Why the study?
What are the diagnostic and therapeutic approaches for managing resistant hypertension?
What are the diagnostic and therapeutic approaches for managing resistant hypertension?
This review highlights spironolactone as an effective add-on therapy for resistant hypertension and discusses emerging non-pharmacological treatments.
Supports spironolactone addition in resistant hypertension; leaves open device therapy roles pending randomized data.
StĂĄle nejsou znĂĄma antihypertenziva, kterĂĄ by dovedla spolehlivÄ snĂĹžit hodnoty krevnĂho tlaku pod 140/90 mm Hg u vĹĄech nemocnĂ˝ch s arteriĂĄlnĂ hypertenzĂ. Tento ÄlĂĄnek shrnuje nÄkterĂŠ osvÄdÄenĂŠ diagnostickĂŠ a terapeutickĂŠ postupy pouĹžĂvanĂŠ v pĂŠÄi o nemocnĂŠ s rezistentnĂ hypertenzĂ. NadÄjnĂ˝m terapeutickĂ˝m pĹĂstupem se zdĂĄ bĂ˝t pĹidĂĄnĂ blokĂĄtoru mineralokortikoidnĂch receptorĹŻ spironolaktonu ke stĂĄvajĂcĂ lĂŠÄbÄ. V prvnĂ ĹadÄ je vĹĄak nutnĂŠ vylouÄit nĂzkou compliance nemocnĂŠho k lĂŠÄbÄ a sekundĂĄrnĂ etiologii hypertenze. Po selhĂĄnĂ veĹĄkerĂŠ farmakoterapie lze zvĂĄĹžit novĂŠ nefarmakologickĂŠ postupy, napĹ. elektrickou stimulaci baroreflexu a denervaci renĂĄlnĂho sympatiku.
No takes yet. Share an insight, caveat, or question.
Robert Holaj (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: